RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials - sprookjes - yvandenbroek - TriplyDB

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

http://www.wikidata.org/entity/Q33768467

about

Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.

P2860

Q48141192-24DBA44F-5A08-41E4-80A5-1DA95A75A6E5

P2860

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

http://www.wikidata.org/entity/Q33768467

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

@ast

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

@en

type

label

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

@ast

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

@en

prefLabel

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

@ast

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

@en

P1433

Q33768467-225BCE6D-0212-4F50-AAC8-CC17CD11953B

P1476

Q33768467-D5FFA16D-152D-4FEE-9836-1549C8876F0D

P2093

Q33768467-0E374970-E7C3-4D27-B558-38E4B5EB5858

Q33768467-10E9ED34-C087-4BE6-9C15-87ABF63E25A6

Q33768467-3E320FE7-4F86-4094-8A86-C20FEF30C2F1

Q33768467-72B3DD6A-EEBF-4315-BDC4-37B8D3B59888

Q33768467-AEC1144B-1649-4A6F-BC70-6187D9078EAC

Q33768467-ED9F4846-D32A-4018-8271-8087DF66F476

P2860

Q33768467-026955DC-E294-448A-B78E-B84B0418547E

Q33768467-0736B1EE-AF01-4B6C-A743-54F42B105258

Q33768467-0A25DA3A-154C-49AF-965E-052B6B088569

Q33768467-0A83C1A7-FB43-4006-96A6-1F941B85E070

Q33768467-0ABC5067-D4AD-43B2-9734-78BD43CC38E9

Q33768467-0EC72FF4-8B84-4EA7-B240-30F0EAF465B9

Q33768467-275150A5-A080-4B57-869C-0D82B398D18B

Q33768467-27E95825-5507-4CDF-B96D-8362B394C444

Q33768467-27F7E2EB-17F0-4771-A672-EC74E83A12FA

Q33768467-30CB4ABE-01A0-4BCB-A655-497775E5D993

P2888

Q33768467-9E64AD6D-1EF6-4066-89D1-2B5E53B172E4

P304

Q33768467-94770B2B-8F54-493B-BA73-5E3BD212245D

P31

Q33768467-4F509784-61FB-4286-B220-EDF2618156FC

P356

Q33768467-E5C8C9B1-581D-41D7-A1B5-A33F0606BF83

P478

Q33768467-7F8202A9-66B8-4957-BED9-0852A10DB7DC

P577

Q33768467-1C1296E9-1CFE-4DE1-8AF0-F93A9E731EBB

P6179

Q33768467-414BEEBD-B853-4A8F-A3FC-8FFE14FD74E9

P698

Q33768467-5B19640D-79CE-4A93-BAF5-0FCB39857568

P932

Q33768467-82FB5B2E-18C2-4541-AB71-8AD5D48EF06F

P356

S40734-017-0055-1

P1433

Journal of clinical movement disorders

P1476

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

@en

P2093

Bahman Jabbari

http://www.w3.org/2001/XMLSchema#string

Diego Torres-Russotto

http://www.w3.org/2001/XMLSchema#string

Jack J Chen

http://www.w3.org/2001/XMLSchema#string

Khashayar Dashtipour

http://www.w3.org/2001/XMLSchema#string

Mark Lew

http://www.w3.org/2001/XMLSchema#string

Roongroj Bhidayasiri

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Drooling of saliva: a review of the etiology and management options.

Long-term follow-up of submandibular duct rerouting for the treatment of sialorrhea in the pediatric population.

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.

Clozapine-induced hypersalivation.

Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the Am

Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis

Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders.

P2888

s40734-017-0055-1

P304

9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40734-017-0055-1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085271244

http://www.w3.org/2001/XMLSchema#string

P698

28593050

http://www.w3.org/2001/XMLSchema#string

P932

5460542

http://www.w3.org/2001/XMLSchema#string